Cost Measurement
Cost measurement is the step in economic evaluation that counts the resources each alternative uses, such as GP visits or bed-days, before they are valued.
Explore comprehensive, evidence-informed explanations of key health economics concepts, including their development, application and relationships to other concepts. Published entries are validated through human expert review.
A concept page is a published entry on the wiki. Some concepts also have a full encyclopaedia article. The Health Economics Ontology (HEO) holds every concept, including dictionary terms without an article, so it is larger than the list of published pages. The knowledge graph shows how concepts relate to each other.
Cost measurement is the step in economic evaluation that counts the resources each alternative uses, such as GP visits or bed-days, before they are valued.
An approach to selecting among interventions already shown to produce equivalent outcomes, in which the choice reduces to the lowest-cost option.
Cost per QALY gained is the extra cost of a treatment compared with an alternative, divided by the quality-adjusted life years (QALYs) it adds.
Cost sharing is the part of the cost of covered care that an insured patient pays directly, through deductibles, co-payments or coinsurance, not premiums.
Cost shifting is the transfer of health care costs from one payer or sector to another, as when hospitals raise private prices after public payment cuts.
Cost valuation is the assignment of monetary values to measured resource use in accordance with a specified perspective, setting, price year, and decision purpose.
Cost-based pricing sets the price of a medicine from its research and development, manufacturing, regulatory and overhead costs plus a profit margin.
Cost-based reimbursement is a provider payment method in which a payer pays a hospital or other provider the costs it incurred, settled after care.
Cost-benefit analysis values the costs and benefits of healthcare options in money, so they can be compared by their net benefit, usually to society.
Cost-consequence analysis sets out the costs and each separate outcome of healthcare options side by side, without combining them into one result.
Cost-effectiveness means an intervention's health gain justifies any extra cost versus an alternative, usually judged by the ICER against a threshold.
A cost-effectiveness acceptability curve (CEAC) plots, across cost-effectiveness thresholds, the probability that each option is the most cost-effective.
The cost-effectiveness acceptability frontier (CEAF) plots the chance the option with the highest expected net benefit is cost-effective, by threshold.
Cost-effectiveness analysis compares healthcare options by the extra cost of each extra unit of health gained, such as cost per life-year gained.
The cost-effectiveness frontier joins the strategies not ruled out by strict or extended dominance on a plot of expected cost against health effect.
A cost-effectiveness league table ranks health care interventions by cost per QALY or a similar ratio so decision makers can compare value for money.
The cost-effectiveness plane graphs incremental cost (y-axis) against incremental effect (x-axis); its four quadrants show dominance or a trade-off.
A cost-effectiveness threshold is the maximum cost per QALY gained that a health system treats as value for money when deciding which treatments to fund.
Cost-minimisation analysis compares only the costs of healthcare options, and is valid only when evidence shows their health outcomes are equivalent.
A cost-of-illness study estimates the economic burden of a disease, including healthcare costs, patient and carer costs, and lost productivity.